The commonly accepted biosynthetic pathway1) leading to erythromycin A (I) requires that substrate for sugars (L-mycarose and Ddesosamine) attachment should be erythronolide B (IV). Once both sugars are linked to the aglycone, giving rise to erythromycin D, C-12 hydroxylation would occur resulting in erythromycin C production.
Erythromycin C is further converted to erythromycin A by O-methylation of the neutral sugar (at C-3").
According The culture for microbial conversion of crythronolide A was prepared as follows: strain ATCC 31772 was inoculated into 100 ml of seed medium consisting of 3.0% sucrose, 0.8% corn steep solids, 0.9 % soybean oil, 0.2 % ammonium sulfate, 0.7 % calcium carbonate, in a 500-m1 Erlenmeyer flask. Following incubation for 2 days at 33°C under shaking at 220 rpm, 1.5 ml of the seed culture were inoculated into 30 ml of a medium containing 3.0% corn dextrins, 4.0 raw corn starch, 3.0% soybean meal, 2.0 soybean oil, 0.2% ammonium sulfate, 0.6 calcium carbonate, in a 250-ml Erlenmeyer flask at 33°C for 120 hours. To the culture was added 500 /cg/ml of crystalline erythronolide A 24 hours after the start of fermentation.
Erythronolide A was detectable in the culture filtrate up to 16 hours after the addition. It disappeared with rapid conversion to erythromycin A alone, as proven by the HPLC procedure of Tsu.I1 et Erythromycin A was isolated from the clarified filtered broth by ethyl acetate extraction at pH 7.0, and purified by column partition chromatography on silica gel" An analytical dihydrate sample was prepared by successive crystallization from chloroform and from water at 50°C: mp200-203°C12) (the crystals were covered with silicone oil and heated in a Kofler apparatus; transformation to an anhydrate form was observed at 110135°C);
Chart 1. Structures of erythromycins A (I), B (H), and erythronolides A (III), B (IV
[a]20D-65° (c 1.0, methanol)13); max 288 nm (s 29.7)14). IR and 13C NMR spectra were identical to corresponding spectra of an authentic sample of erythromycin A.
In conclusion these results provide good evidence that erythronolide A could be an intermediate of erythromycin A biosynthesis. Neither permeation barriers nor steric hindrance oppose the conversion of erythronolide A to erythromycin A under the conditions employed. Failure to obtain blocked mutants accumulating erythronolide A or 3-O-mycarosylerythronolide A, might possibly be explained by an inducible nature of C-12 hydroxylase formation (which would require the presence of erythromycin D to be expressed), or, alternatively, by an "assembly-line" arrangement of the concerned biosynthetic enzymes, the hydroxylase coming after both glycosidases in the sequence. Besides, we cannot exclude that, at least for some strains, a pathway other than the commonly accepted one could lead to formation of erythromycin A.
It is well known that the C-12 hydroxyl group enhances the biological activity of erythromycin15); correspondingly, the results presented here also point to the possibility of using certain lactones of erythronolide A type for the biological synthesis of new antibiotics by the Streptomyces erythraeus ATCC 31772.
